Mechanistic description
In AD, blocking TNF-α/IL-6 triggers compensatory upregulation of alternative inflammatory cascades (IL-1β, NLRP3) that don’t exist in cardiovascular disease. This creates therapeutic resistance unique to neuroinflammation.
Mechanism / pathway
- NLRP3
- clinical neurology
Evidence for (5)
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
NLRP3 inflammasome in neuroinflammation and central nervous system diseases.
Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke.
Ripks and Neuroinflammation.
Inflammatory aspects of Alzheimer's disease.
Evidence against (1)
Evidence matrix
Supporting
- Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? PMID:33318676 · 2021 · Nat Rev Neurol
- NLRP3 inflammasome in neuroinflammation and central nervous system diseases. PMID:40075143 · 2025 · Cell Mol Immunol
- Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke. PMID:38701781 · 2024 · Cell Rep Med
- Ripks and Neuroinflammation. PMID:38349514 · 2024 · Mol Neurobiol
- Inflammatory aspects of Alzheimer's disease. PMID:39196440 · 2024 · Acta Neuropathol
Contradicting
No contradicting evidence recorded.
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Compensatory Cytokine Network Activation. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/hyp-SDA-2026-04-08-gap-debate-20260406-062045-ce866189-1
@misc{scidex_hypothesis_hypsda20,
title = {Compensatory Cytokine Network Activation},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/hyp-SDA-2026-04-08-gap-debate-20260406-062045-ce866189-1},
note = {SciDEX artifact hypothesis:hyp-SDA-2026-04-08-gap-debate-20260406-062045-ce866189-1}
}